BioTrace Medical

BioTrace Medical is a medical technology company that developed the Tempo Temporary Pacing Lead, a specialized device designed for use during transcatheter aortic valve replacement (TAVR) and other complex interventional procedures. The Tempo Lead is engineered to provide secure, stable cardiac pacing while minimizing the risk of complications such as cardiac perforation, which is a common concern with traditional temporary leads. By featuring a unique bipolar design with a soft tip and an active fixation mechanism, the device allows for safer and more reliable rapid pacing. The company was acquired by Merit Medical Systems in 2020, integrating its innovative pacing technology into a broader portfolio of cardiovascular intervention tools.